Trial Profile
A multicenter, randomized trial comparing a combined gemcitabine and cisplatin 3-week regimen with a 4-week regimen in non-small cell lung cancer patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2008
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 25 Jun 2007 New trial record.